Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Infinity Pharmaceuticals (United States) | Researchclopedia

Back to institutions

Infinity Pharmaceuticals (United States)

Cambridge, Massachusettscompany

274

Works

118,790

Citations

206

h-index

Top Research Topics

Chronic Lymphocytic Leukemia Research Hedgehog Signaling Pathway Studies Lymphoma Diagnosis and Treatment

Top Researchers

Kenneth C. Anderson Boston University

3,074 works167,484 citationsh-index: 199

Recent Research

Mapping study on AI-based technologies in palliative care – a scoping study

Mariana Silva-Ferreira,Sara Cruz,et al.

20253 citations

Heat shock proteins research

Epigenetics and DNA Methylation

Cancer Immunotherapy and Biomarkers

PI3K/AKT/mTOR signaling in cancer

Chronic Myeloid Leukemia Treatments

Cancer-related Molecular Pathways

Computational Drug Discovery Methods

Ubiquitin and proteasome pathways

Immunodeficiency and Autoimmune Disorders

Benjamin L. Ebert RWTH Aachen University

765 works153,443 citationsh-index: 122

Paul G. Richardson Boston University

2,057 works131,367 citationsh-index: 170

Pasi A. Jänne Harvard University

2,338 works125,624 citationsh-index: 163

Charles S. Fuchs Yale Cancer Center

1,719 works113,235 citationsh-index: 171

Mithat Gönen Memorial Sloan Kettering Cancer Center

1,348 works101,878 citationsh-index: 156

Monkeypox Virus in high-risk population groups: Clinical course and Implications

Varun Pandey,Preeti Shahi,et al.

20250 citations

Eganelisib combined with immune checkpoint inhibitor therapy and chemotherapy in frontline metastatic triple-negative breast cancer triggers macrophage reprogramming, immune activation and extracellular matrix reorganization in the tumor microenvironment

Brenda O’Connell,Charley Hubbard,et al.

202448 citations

PI3Kγ inhibition circumvents inflammation and vascular leak in SARS-CoV-2 and other infections

Ryan M. Shepard,Anghesom Ghebremedhin,et al.

20248 citations

First-in-Human Phase 1 Randomized Trial with the Anti-CD40 Monoclonal Antibody KPL-404: Safety, Tolerability, Receptor Occupancy, and Suppression of T-Cell–Dependent Antibody Response

Manoj Samant,John A. Ziemniak,et al.

20237 citations

NCCN Guidelines® Insights: Biliary Tract Cancers, Version 2.2023

Al B. Benson,Michael I. D’Angelica,et al.

2023194 citations